- By Anton Grillo
- (General Dispatch) – The U.S. Army expressed its concern on Thursday about the difficulties faced by the Johnson & Johnson Company, which has represented an obstacle for the supply of the vaccine to troops serving abroad.
- Only 40% of the total numbers of U.S. military personnel serving abroad have received the vaccine.
- The information, which affects an important security sector of the United States, was released at a press conference held at the Pentagon.
- In retrospect, everything seems to indicate that last month the Johnson & Johnson factory discarded 15 million doses of vaccine because it did not meet quality standards.
- It is worth noting that the turnout has caused frustration for many soldiers and their families who are serving in the military to ensure the nation’s security and are a vulnerable fraction to the Chinese coronavirus.
- It is important to note that only 7% of Department of Defense personnel are operating overseas, therefore, only 14% of the vaccines have been provided.
- It is important to mention that covid-19 outbreaks are present around the globe, and virus infections may represent an importation of new outbreaks if vaccine administration is not prioritized.
- Finally, Army Lieutenant General Ronald J. Place told reporters on the scene that Joe Biden’s administration is expediting the process to achieve the goal of immunizing the Pentagon team.
Adittional Information:
Breitbart: J&J vaccine problems hamper US military vaccines overseas
AP News: J&J vaccine problems hamper US military vaccines overseas
Related Articles
